1. Home
  2. USEG vs SCLX Comparison

USEG vs SCLX Comparison

Compare USEG & SCLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo U.S. Energy Corp. (DE)

USEG

U.S. Energy Corp. (DE)

HOLD

Current Price

$1.01

Market Cap

46.5M

Sector

Energy

ML Signal

HOLD

Logo Scilex Holding Company

SCLX

Scilex Holding Company

HOLD

Current Price

$9.38

Market Cap

48.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
USEG
SCLX
Founded
1966
2011
Country
United States
United States
Employees
N/A
34
Industry
Oil & Gas Production
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
46.5M
48.5M
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
USEG
SCLX
Price
$1.01
$9.38
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
1.7M
107.8K
Earning Date
05-07-2026
04-10-2026
Dividend Yield
N/A
N/A
EPS Growth
55.21
N/A
EPS
N/A
N/A
Revenue
$32,379,000.00
N/A
Revenue This Year
$114,854.51
$122.52
Revenue Next Year
N/A
$186.30
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.66
$4.20
52 Week High
$2.75
$34.27

Technical Indicators

Market Signals
Indicator
USEG
SCLX
Relative Strength Index (RSI) 56.25 64.23
Support Level $0.94 $7.73
Resistance Level $1.08 $9.00
Average True Range (ATR) 0.05 0.75
MACD 0.00 0.14
Stochastic Oscillator 85.80 79.81

Price Performance

Historical Comparison
USEG
SCLX

About USEG U.S. Energy Corp. (DE)

US Energy Corp is an independent energy company. It is focused on the acquisition and development of oil and natural gas-producing properties in the continental United States. It has business properties and operations in the Rockies region (Montana, Wyoming, and North Dakota), the Mid-Continent (Oklahoma, Kansas, and North and East Texas), and the West Texas, South Texas, and Gulf Coast regions. The company generates revenue from its interest in the sales of oil and natural gas production. The group operates in the exploration and production segment of the oil and gas industry, onshore in the United States.

About SCLX Scilex Holding Company

Scilex Holding Co is focused on acquiring, developing and commercializing non-opioid pain management products for the treatment of acute and chronic pain. It targets indications with high unmet needs and large market opportunities with non-opioid therapies for the treatment of patients with acute and chronic pain and are dedicated to advancing and improving patient outcomes. Its commercial products are: ZTlidoO for the relief of neuropathic pain associated with postherpetic neuralgia (PHN), which is a form of post-shingles nerve pain; ELYXYB, a potential first-line treatment ready-to-use oral solution for the acute treatment of migraine in adults and GLOPERBA, the liquid oral version of the anti-gout medicine colchicine indicated for the prophylaxis of painful gout flares in adults.

Share on Social Networks: